How much funding has Isomorphic Labs raised?

Isomorphic Labs has raised $2.6B in total funding, most recently a Venture Round.

Who are Isomorphic Labs's investors?

Isomorphic Labs's investors include Thrive Capital, GV, Alphabet.

When was Isomorphic Labs founded?

Isomorphic Labs was founded in 2021.

Where is Isomorphic Labs headquartered?

Isomorphic Labs is headquartered in London, United Kingdom.

What industry is Isomorphic Labs in?

Isomorphic Labs operates in Artificial Intelligence, Biotech, Life Sciences.

How many employees does Isomorphic Labs have?

Isomorphic Labs has 201-500 employees.

Isomorphic Labs

Solve all disease

London, United Kingdom · Founded 2021 · $2.6B raised

Artificial Intelligence

Biotech

Life Sciences

Headquarters: London
Employees: 201–500
Founded: 2021
Business Model: B2B

Website: isomorphiclabs.com
Total Funding: $2.6B
Last Round: $2.0B Venture RoundMay 2026
Rounds: 2

About

Isomorphic Labs is an AI-first drug discovery company spun out of Google DeepMind, built on the Nobel Prize-winning AlphaFold protein structure prediction system. Its interdisciplinary team of machine learning researchers and drug discovery scientists has developed a unified Drug Design Engine capable of rationally designing novel molecules at digital speed. The company partners with major biopharma firms including Eli Lilly, Novartis, and Johnson & Johnson to co-develop therapeutics.

Summary

Isomorphic Labs is an Artificial Intelligence company based in London, United Kingdom, founded in 2021. It has raised $2.6B in total across 2 rounds, most recently a $2.0B Venture Round round in May 2026. Investors include Thrive Capital, GV and Alphabet.

LinkedIn X (Twitter)GitHub